<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id><journal-title>BMC Medical Genetics</journal-title><issn pub-type="epub">1471-2350</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2350-5-29</article-id><article-id pub-id-type="pmid">15610558</article-id><article-id pub-id-type="doi">10.1186/1471-2350-5-29</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Allele frequencies of hemojuvelin gene (<italic>HJV</italic>) I222N and G320V missense mutations in white and African American subjects from the general Alabama population</article-title></title-group><contrib-group><contrib id="A1" equal-contrib="yes" contrib-type="author"><name><surname>Barton</surname><given-names>James C</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>ironmd@dnamail.com</email></contrib><contrib id="A2" equal-contrib="yes" contrib-type="author"><name><surname>Rivers</surname><given-names>Charles A</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>rivers@uab.edu</email></contrib><contrib id="A3" equal-contrib="yes" contrib-type="author"><name><surname>Niyongere</surname><given-names>Sandrine</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>sniyong@uab.edu</email></contrib><contrib id="A4" equal-contrib="yes" contrib-type="author"><name><surname>Bohannon</surname><given-names>Sean B</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>sbbohannon@bosco.meis.uab.edu</email></contrib><contrib id="A5" equal-contrib="yes" corresp="yes" contrib-type="author"><name><surname>Acton</surname><given-names>Ronald T</given-names></name><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><email>acton@uab.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Southern Iron Disorders Center, Birmingham, Alabama</aff><aff id="I2"><label>2</label>Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama</aff><aff id="I3"><label>3</label>Immunogenetics Program and Departments of Microbiology and Epidemiology and International Health, University of Alabama at Birmingham, Birmingham, Alabama</aff><pub-date pub-type="collection"><year>2004</year></pub-date><pub-date pub-type="epub"><day>20</day><month>12</month><year>2004</year></pub-date><volume>5</volume><fpage>29</fpage><lpage>29</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/5/29"/><history><date date-type="received"><day>18</day><month>8</month><year>2004</year></date><date date-type="accepted"><day>20</day><month>12</month><year>2004</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2004 Barton et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2004</copyright-year><copyright-holder>Barton et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Barton C James ironmd@dnamail.com </dc:author><dc:title> Allele frequencies of hemojuvelin gene (HJV) I222N and G320V missense mutations in white and African American subjects from the general Alabama population </dc:title><dc:date>2004</dc:date><dcterms:bibliographicCitation>BMC Medical Genetics 5(1): 29-. (2004)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2350(2004)5:1&#x0003c;29&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2350</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Homozygosity or compound heterozygosity for coding region mutations of the hemojuvelin gene (<italic>HJV</italic>) in whites is a cause of early age-of-onset iron overload (juvenile hemochromatosis), and of hemochromatosis phenotypes in some young or middle-aged adults. <italic>HJV </italic>coding region mutations have also been identified recently in African American primary iron overload and control subjects. Primary iron overload unexplained by typical hemochromatosis-associated <italic>HFE </italic>genotypes is common in white and black adults in Alabama, and <italic>HJV </italic>I222N and G320V were detected in a white Alabama juvenile hemochromatosis index patient. Thus, we estimated the frequency of the <italic>HJV </italic>missense mutations I222N and G320V in adult whites and African Americans from Alabama general population convenience samples.</p></sec><sec sec-type="methods"><title>Methods</title><p>We evaluated the genomic DNA of 241 Alabama white and 124 African American adults who reported no history of hemochromatosis or iron overload to detect HJV missense mutations I222N and G320V using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. Analysis for HJV I222N was performed in 240 whites and 124 African Americans. Analysis for HJV G320V was performed in 241 whites and 118 African Americans.</p></sec><sec><title>Results</title><p>One of 240 white control subjects was heterozygous for <italic>HJV </italic>I222N; she was also heterozygous for <italic>HFE </italic>C282Y, but had normal serum iron measures and bone marrow iron stores. <italic>HJV </italic>I222N was not detected in 124 African American subjects. <italic>HJV </italic>G320V was not detected in 241 white or 118 African American subjects.</p></sec><sec><title>Conclusions</title><p><italic>HJV </italic>I222N and G320V are probably uncommon causes or modifiers of primary iron overload in adult whites and African Americans in Alabama. Double heterozygosity for <italic>HJV </italic>I222N and <italic>HFE </italic>C282Y may not promote increased iron absorption.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Homozygosity or compound heterozygosity for coding region mutations of the hemojuvelin gene (<italic>HJV</italic>) in whites is a cause of early age-of-onset iron overload (juvenile hemochromatosis), and of hemochromatosis phenotypes in some young or middle-aged adults [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B4">4</xref>]. <italic>HJV </italic>coding region mutations have also been identified recently in African American primary iron overload and control subjects [<xref ref-type="bibr" rid="B5">5</xref>]. We estimated the frequency of the <italic>HJV </italic>missense mutations I222N and G320V in Alabama white and African American adults who reported no history of hemochromatosis or iron overload, because primary iron overload unexplained by typical hemochromatosis-associated <italic>HFE </italic>genotypes is common in whites and blacks in Alabama [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>], and <italic>HJV </italic>I222N and G320V were detected in an Alabama juvenile hemochromatosis index patient [<xref ref-type="bibr" rid="B3">3</xref>]. In addition, <italic>HJV </italic>I222N and G320V have been described in white adults with hemochromatosis phenotypes in other geographic areas [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B9">9</xref>].</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>General criteria for selection of study subjects</title><p>Performance of this study was approved by the Institutional Review Boards of the University of Alabama at Birmingham and Brookwood Medical Center. Unrelated white subjects were spouses of patients who attended a hematology and medical oncology outpatient clinic; hospital employees; and controls who participated in a sleep study. Unrelated control black subjects were spouses of patients who attended a hematology and medical oncology outpatient clinic; hospital employees; controls who participated in a sleep study; and controls who participated in a study of gestational diabetes mellitus. All subjects were adults (&#x02265; 18 years old). No subject reported a previous diagnosis of hemochromatosis or iron overload. Serum transferrin saturation, serum ferritin concentration, or other indicators of iron metabolism were not measured in most study subjects.</p></sec><sec><title>Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analyses</title><p>Genomic DNA was isolated from blood buffy coat as described previously [<xref ref-type="bibr" rid="B6">6</xref>]. <italic>HJV </italic>I222N and G320V were genotyped by standard PCR-RFLP and agarose electrophoresis techniques. Exon 4 of the <italic>HJV </italic>locus was amplified using the primers HJEx4AF and HJEx4BR previously described [<xref ref-type="bibr" rid="B3">3</xref>]; this allowed for the amplification of the region containing both the I222N and G320V mutations of the <italic>HJV </italic>locus. Reaction conditions were as follows: 10 mM KCl, 10 mM (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 20 mM Tris-HCl (pH 8.8), 0.1% Triton X-100, 3.2 mM MgSO<sub>4</sub>, 200 &#x003bc;M dATP, 200 &#x003bc;M dCTP, 200 &#x003bc;M dGTP, 200 &#x003bc;M dTTP, 1 &#x003bc;M of each primer, 0.2 U/&#x003bc;L of Taq Polymerase. Amplification conditions on a Biometra UNO II thermocycler (LabRepCo/LabRepNet, Horsham, PA) consisted of an initial denaturing at 94&#x000b0;C for five minutes followed by thirty cycles of 94&#x000b0;C for 30 seconds, 60&#x000b0;C for 30 seconds and 72&#x000b0;C for 30 seconds.</p><p>Delineation of c.665T&#x02192;A of the <italic>HJV </italic>exon 4 nucleotide sequence defining I222N was made utilizing the restriction endonuclease Bcc I (New England Biolabs, Beverly, MA), which recognizes the nucleotide c.665T of I222 as a restriction site, and not the nucleotide c.665A of N222. Similarly, the nucleotide polymorphism site c.959G&#x02192;T defining the G320V polymorphism of the <italic>HJV </italic>exon 4 locus was determined by using the restriction endonuclease Ban I (New England Biolabs, Beverly, MA). Ban I recognizes the nucleotide c.959G of G320 as part of the restriction site sequence, but not the nucleotide c.959T of V320. DNA specimens from the parents of a white juvenile hemochromatosis index case were used as positive controls for <italic>HJV </italic>I222N and G320V [<xref ref-type="bibr" rid="B3">3</xref>].</p></sec><sec><title>Statistical considerations</title><p>The data set consisted of observations on 241 Alabama white and 124 African American adults. Analysis for <italic>HJV </italic>I222N was performed in 240 whites and 124 African Americans. Analysis for <italic>HJV </italic>G320V was performed in 241 whites and 118 African Americans. Results are expressed as allele frequencies and 95% confidence intervals (CI). To estimate the CI for frequencies of <italic>HJV </italic>mutations that were not detected in the present subjects, we computed the allele frequency as the quotient of single minimal hypothetical value (= 0.01) and the number of chromosomes corresponding to the respective groups of subjects. Computations were performed with GB-STAT (v10.0; Dynamic Microsystems, Inc., Silver Spring, MD).</p></sec></sec><sec><title>Results</title><sec><title>Allele frequencies of <italic>HJV </italic>I222N and G320V</title><p>These results are displayed in Table <xref ref-type="table" rid="T1">1</xref>. One of 240 white subjects was heterozygous for <italic>HJV </italic>I222N, but this mutation was not detected in African American subjects. <italic>HJV </italic>G320V was not detected in either white or African American subjects.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p><italic>HJV </italic>missense mutations in Alabama adult subjects from the general population.<sup>1</sup></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><italic>HJV </italic>mutation</td><td align="left">I222N</td><td align="left">G320V</td></tr></thead><tbody><tr><td align="left">Whites tested, n</td><td align="left">240</td><td align="left">241</td></tr><tr><td align="left">Whites with mutation, n</td><td align="left">1 (heterozygote)</td><td align="left">0</td></tr><tr><td align="left">Allele frequency (95% CI)</td><td align="left">0.0021 (0, 0.0062)</td><td align="left">0 (0, ~0.00006)</td></tr><tr><td></td><td></td><td></td></tr><tr><td align="left">African Americans tested, n</td><td align="left">124</td><td align="left">118</td></tr><tr><td align="left">African Americans with mutation, n</td><td align="left">0</td><td align="left">0</td></tr><tr><td align="left">Allele frequency (95% CI)</td><td align="left">0 (0, ~0.00012)</td><td align="left">0 (0, ~0.00013)</td></tr></tbody></table><table-wrap-foot><p><sup>1</sup><italic>HJV </italic>mutations were detected using PCR-RFLP technique. DNA specimens from the parents of a white juvenile hemochromatosis index case were used as positive controls for <italic>HJV </italic>I222N and G320V [3]. CI = confidence interval.</p></table-wrap-foot></table-wrap></sec><sec><title>Characteristics of a <italic>HJV </italic>I222N heterozygote</title><p>Medical records of the white subject heterozygous for <italic>HJV </italic>I222N were available for review. This 29 year-old woman was also heterozygous for <italic>HFE </italic>C282Y. She reported that she had had two normal pregnancies and one spontaneous abortion. She has always experienced heavy menstrual flow, but she reported no other significant blood loss. She reported no blood donation. She reported that she eats a variety of meats, vegetables, and other foods; there was no history of supplemental iron ingestion. Her hemoglobin level was 12.8 g/dL, platelets 113,000/mm<sup>3</sup>, transferrin saturation 21%, and serum ferritin 23 ng/mL; marrow examination performed to evaluate thrombocytopenia revealed normal cellular morphology and normal iron stores.</p></sec></sec><sec><title>Discussion</title><p>A variety of <italic>HJV </italic>coding region mutations occur in homozygous or compound heterozygous configuration in persons with juvenile or adult-onset hemochromatosis phenotypes [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>]. However, these types of <italic>HJV</italic>-associated hemochromatosis are collectively uncommon [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. <italic>HJV </italic>mutations were also uncommon in control whites studied with dHPLC (denaturing high-performance liquid chromatography) [<xref ref-type="bibr" rid="B9">9</xref>]. In 200 Greek volunteer blood donors, none carried the <italic>HJV </italic>G320V mutation detectable by PCR-RFLP analysis, suggesting that the frequency of the G320V allele in the Greek population is lower than 0.004 [<xref ref-type="bibr" rid="B11">11</xref>]. In French control subjects, for example, only the <italic>HJV </italic>missense mutations L101P (two heterozygotes) and E302K (one heterozygote) were identified in 333 control subjects, representing an aggregate <italic>HJV </italic>mutation frequency of 0.0045 (95% CI: 0, 0.0096) [<xref ref-type="bibr" rid="B9">9</xref>]. The present results in Alabama white control subjects are consistent with these previous reports. Taken together, these observations confirm and extend previous observations that the individual or aggregate frequency of <italic>HJV </italic>coding region mutations is low in general populations of whites [<xref ref-type="bibr" rid="B9">9</xref>].</p><p>Heterozygosity for a <italic>HJV </italic>missense mutation was associated with increased severity of iron overload in nine of 310 French patients with hemochromatosis and <italic>HFE </italic>C282Y homozygosity who were studied with dHPLC [<xref ref-type="bibr" rid="B9">9</xref>]. In 48 white U.S. hemochromatosis patients with <italic>HFE </italic>C282Y homozygosity studied with dHPLC, no <italic>HJV </italic>coding region mutation was detected [<xref ref-type="bibr" rid="B5">5</xref>]. Thus, aggregate <italic>HJV </italic>coding region mutation frequencies in C282Y homozygotes with a hemochromatosis phenotype in France and the U.S. are similar (0.0148 vs. 0, respectively; p = 0.2716, Fisher exact test). The aggregate frequency of <italic>HJV </italic>coding region mutations was similar in French hemochromatosis patients with <italic>HFE </italic>C282Y homozygosity and in French control subjects (0.0145 vs. 0.0045, respectively; p = 0.0564, Fisher exact test), although the hemochromatosis patients with <italic>HJV </italic>coding region mutations had more severe iron overload, on the average, than did hemochromatosis patients without <italic>HJV </italic>coding region mutations [<xref ref-type="bibr" rid="B9">9</xref>].</p><p>Double heterozygosity for <italic>HJV </italic>I222N and <italic>HFE </italic>C282Y was not associated with evidence of increased iron absorption in the present case. Some persons with JH have common <italic>HFE </italic>genotypes, including C282Y heterozygosity, H63D heterozygosity or homozygosity, and S65C heterozygosity [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. However, these <italic>HFE </italic>genotypes are infrequently associated with a severe hemochromatosis phenotype [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B25">25</xref>]. Further, sequencing <italic>HFE </italic>introns and exons in English and French Canadian JH cases did not reveal novel <italic>HFE </italic>mutations that could likely explain the development of iron overload [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. In 310 C282Y homozygotes in France, <italic>HJV </italic>mutations were relatively common and were associated with greater severity of iron overload [<xref ref-type="bibr" rid="B9">9</xref>]. In 48 C282Y homozygotes in the U.S. who had severe iron overload phenotypes, no <italic>HJV </italic>coding region mutation was detected [<xref ref-type="bibr" rid="B5">5</xref>]. The frequency of H63D is significantly greater in persons with cardiomyopathy than in normal control subjects [<xref ref-type="bibr" rid="B26">26</xref>]. The brother of a Spanish JH proband had evidence of iron overload associated with H63D homozygosity and heterozygosity for a putative JH-associated Ch1q haplotype [<xref ref-type="bibr" rid="B17">17</xref>]. Although these reports are consistent with observations in another JH patient with cardiomyopathy who had <italic>HFE </italic>H63D [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B12">12</xref>], other persons with JH and cardiomyopathy did not have H63D [<xref ref-type="bibr" rid="B15">15</xref>]. Altogether, these reports indicate that further exploration of the potential role of variant <italic>HJV </italic>alleles in the clinical expression of iron overload with particular reference to <italic>HFE </italic>hemochromatosis is warranted [<xref ref-type="bibr" rid="B2">2</xref>], and that the frequency and biological significance of <italic>HJV </italic>alleles may vary among racial/ethnic groups.</p><p>Primary iron overload in African Americans is phenotypically and genetically heterogeneous [<xref ref-type="bibr" rid="B8">8</xref>]. Some patients have common <italic>HFE </italic>mutations, a common allele of the ferroportin gene (<italic>FPN1 </italic>Q248H), or heritable types of anemia [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>], but the genetic basis of most cases remains unknown. <italic>HJV </italic>I222N and G320V were not detected in the present African American subjects. However, <italic>HJV </italic>coding region mutations were recently identified in two of 51 African American subjects with iron overload: exon 3, nt 205&#x02013;207 ins GGA (ins G69) (frequency 0.0098); and exon 4, nt 929 C&#x02192;G (A310G) (allele frequency 0.0196) [<xref ref-type="bibr" rid="B5">5</xref>]. The <italic>HJV </italic>alleles ins G69 and A310G were also identified in African American control subjects (allele frequencies 0.0038 and 0.0720, respectively) [<xref ref-type="bibr" rid="B5">5</xref>]. Taken together, these observations suggest that <italic>HJV </italic>coding region mutations are uncommon in African Americans, but may account for some cases of primary iron overload [<xref ref-type="bibr" rid="B5">5</xref>].</p></sec><sec><title>Conclusions</title><p><italic>HJV </italic>I222N and G320V are uncommon causes or modifiers of primary iron overload in adult whites and African Americans in Alabama. Double heterozygosity for <italic>HJV </italic>I222N and <italic>HFE </italic>C282Y may not promote increased iron absorption.</p></sec><sec><title>Competing interests</title><p>The author(s) declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>JCB participated in conceiving the study, provided DNA specimens, performed statistical evaluation, and wrote part of the manuscript. CAR devised the PCR-RFLP assay, provided DNA specimens, participated in data collection, and wrote part of the manuscript. SN and SB performed testing on DNA specimens and participated in data collection. RTA participated in conceiving the study, provided DNA specimens, and wrote part of the manuscript. All authors approved the final version of the manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/5/29/prepub"/></p></sec></body><back><ack><sec><title>Acknowledgments</title><p>This work was supported in part by the Immunogenetics Program, U.S. Department of Education McNair Scholars Program grant P217A030260, National Institutes of Health/ National Heart, Lung, and Blood Institute Short-Term Training Grant for Students in Health Professional Schools T35 HL07473, and Southern Iron Disorders Center.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Papanikolaou</surname><given-names>G</given-names></name><name><surname>Samuels</surname><given-names>ME</given-names></name><name><surname>Ludwig</surname><given-names>EH</given-names></name><name><surname>MacDonald</surname><given-names>ML</given-names></name><name><surname>Franchini</surname><given-names>PL</given-names></name><name><surname>Dube</surname><given-names>MP</given-names></name><name><surname>Andres</surname><given-names>L</given-names></name><name><surname>MacFarlane</surname><given-names>J</given-names></name><name><surname>Sakellaropoulos</surname><given-names>N</given-names></name><name><surname>Politou</surname><given-names>M</given-names></name><name><surname>Nemeth</surname><given-names>E</given-names></name><name><surname>Thompson</surname><given-names>J</given-names></name><name><surname>Risler</surname><given-names>JK</given-names></name><name><surname>Zaborowska</surname><given-names>C</given-names></name><name><surname>Babakaiff</surname><given-names>R</given-names></name><name><surname>Radomski</surname><given-names>CC</given-names></name><name><surname>Pape</surname><given-names>TD</given-names></name><name><surname>Davidas</surname><given-names>O</given-names></name><name><surname>Christakis</surname><given-names>J</given-names></name><name><surname>Brissot</surname><given-names>P</given-names></name><name><surname>Lockitch</surname><given-names>G</given-names></name><name><surname>Ganz</surname><given-names>T</given-names></name><name><surname>Hayden</surname><given-names>MR</given-names></name><name><surname>Goldberg</surname><given-names>YP</given-names></name></person-group><article-title>Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis</article-title><source>Nat Genet</source><year>2004</year><volume>36</volume><fpage>77</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">14647275</pub-id><pub-id pub-id-type="doi">10.1038/ng1274</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lanzara</surname><given-names>C</given-names></name><name><surname>Roetto</surname><given-names>A</given-names></name><name><surname>Daraio</surname><given-names>F</given-names></name><name><surname>Rivard</surname><given-names>S</given-names></name><name><surname>Ficarella</surname><given-names>R</given-names></name><name><surname>Simard</surname><given-names>H</given-names></name><name><surname>Cox</surname><given-names>TM</given-names></name><name><surname>Cazzola</surname><given-names>M</given-names></name><name><surname>Piperno</surname><given-names>A</given-names></name><name><surname>Gimenez-Roqueplo</surname><given-names>AP</given-names></name><name><surname>Grammatico</surname><given-names>P</given-names></name><name><surname>Volinia</surname><given-names>S</given-names></name><name><surname>Gasparini</surname><given-names>P</given-names></name><name><surname>Camaschella</surname><given-names>C</given-names></name></person-group><article-title>Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis</article-title><source>Blood</source><year>2004</year><volume>103</volume><fpage>4317</fpage><lpage>4321</lpage><pub-id pub-id-type="pmid">14982873</pub-id><pub-id pub-id-type="doi">10.1182/blood-2004-01-0192</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>PL</given-names></name><name><surname>Beutler</surname><given-names>E</given-names></name><name><surname>Rao</surname><given-names>SV</given-names></name><name><surname>Barton</surname><given-names>JC</given-names></name></person-group><article-title>Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin</article-title><source>Blood</source><year>2004</year><volume>103</volume><fpage>4669</fpage><lpage>4671</lpage><pub-id pub-id-type="pmid">14982867</pub-id><pub-id pub-id-type="doi">10.1182/blood-2004-01-0072</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robson</surname><given-names>KJ</given-names></name><name><surname>Merryweather-Clarke</surname><given-names>AT</given-names></name><name><surname>Cadet</surname><given-names>E</given-names></name><name><surname>Viprakasit</surname><given-names>V</given-names></name><name><surname>Zaahl</surname><given-names>MG</given-names></name><name><surname>Pointon</surname><given-names>JJ</given-names></name><name><surname>Weatherall</surname><given-names>DJ</given-names></name><name><surname>Rochette</surname><given-names>J</given-names></name></person-group><article-title>Recent advances in understanding haemochromatosis: a transition state</article-title><source>J Med Genet</source><year>2004</year><volume>41</volume><fpage>721</fpage><lpage>730</lpage><pub-id pub-id-type="pmid">15466004</pub-id><pub-id pub-id-type="doi">10.1136/jmg.2004.020644</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>PL</given-names></name><name><surname>Barton</surname><given-names>JC</given-names></name><name><surname>Brandhagen</surname><given-names>D</given-names></name><name><surname>Beutler</surname><given-names>E</given-names></name></person-group><article-title>Hemojuvelin (HJV) mutations in persons of European, African-American and Asian ancestry with adult onset haemochromatosis</article-title><source>Br J Haematol</source><year>2004</year><volume>127</volume><fpage>224</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">15461631</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2141.2004.05165.x</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barton</surname><given-names>JC</given-names></name><name><surname>Shih</surname><given-names>WW</given-names></name><name><surname>Sawada-Hirai</surname><given-names>R</given-names></name><name><surname>Acton</surname><given-names>RT</given-names></name><name><surname>Harmon</surname><given-names>L</given-names></name><name><surname>Rivers</surname><given-names>C</given-names></name><name><surname>Rothenberg</surname><given-names>BE</given-names></name></person-group><article-title>Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis</article-title><source>Blood Cells Mol Dis</source><year>1997</year><volume>23</volume><fpage>135</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">9215758</pub-id><pub-id pub-id-type="doi">10.1006/bcmd.1997.0129</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barton</surname><given-names>JC</given-names></name><name><surname>Sawada-Hirai</surname><given-names>R</given-names></name><name><surname>Rothenberg</surname><given-names>BE</given-names></name><name><surname>Acton</surname><given-names>RT</given-names></name></person-group><article-title>Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands</article-title><source>Blood Cells Mol Dis</source><year>1999</year><volume>25</volume><fpage>147</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">10575540</pub-id><pub-id pub-id-type="doi">10.1006/bcmd.1999.0240</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barton</surname><given-names>JC</given-names></name><name><surname>Acton</surname><given-names>RT</given-names></name><name><surname>Rivers</surname><given-names>CA</given-names></name><name><surname>Bertoli</surname><given-names>LF</given-names></name><name><surname>Gelbart</surname><given-names>T</given-names></name><name><surname>West</surname><given-names>C</given-names></name><name><surname>Beutler</surname><given-names>E</given-names></name></person-group><article-title>Genotypic and phenotypic heterogeneity of African Americans with primary iron overload</article-title><source>Blood Cells Mol Dis</source><year>2003</year><volume>31</volume><fpage>310</fpage><lpage>319</lpage><pub-id pub-id-type="pmid">14636644</pub-id><pub-id pub-id-type="doi">10.1016/S1079-9796(03)00166-9</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Gac</surname><given-names>G</given-names></name><name><surname>Scotet</surname><given-names>V</given-names></name><name><surname>Ka</surname><given-names>C</given-names></name><name><surname>Gourlaouen</surname><given-names>I</given-names></name><name><surname>Bryckaert</surname><given-names>L</given-names></name><name><surname>Jacolot</surname><given-names>S</given-names></name><name><surname>Mura</surname><given-names>C</given-names></name><name><surname>Ferec</surname><given-names>C</given-names></name></person-group><article-title>The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype</article-title><source>Hum Mol Genet</source><year>2004</year><volume>13</volume><fpage>1913</fpage><lpage>1918</lpage><pub-id pub-id-type="pmid">15254010</pub-id><pub-id pub-id-type="doi">10.1093/hmg/ddh206</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>FW</given-names></name><name><surname>Rubio-Aliaga</surname><given-names>I</given-names></name><name><surname>Kushner</surname><given-names>JP</given-names></name><name><surname>Andrews</surname><given-names>NC</given-names></name><name><surname>Fleming</surname><given-names>MD</given-names></name></person-group><article-title>Identification of a novel mutation (C321X) in HJV</article-title><source>Blood</source><year>2004</year><volume>104</volume><fpage>2176</fpage><lpage>2177</lpage><pub-id pub-id-type="pmid">15138164</pub-id><pub-id pub-id-type="doi">10.1182/blood-2004-01-0400</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pissia</surname><given-names>M</given-names></name><name><surname>Polonifi</surname><given-names>K</given-names></name><name><surname>Politou</surname><given-names>M</given-names></name><name><surname>Lilakos</surname><given-names>K</given-names></name><name><surname>Sakellaropoulos</surname><given-names>N</given-names></name><name><surname>Papanikolaou</surname><given-names>G</given-names></name></person-group><article-title>Prevalence of the G320V mutation of the HJV gene, associated with juvenile hemochromatosis, in Greece</article-title><source>Haematologica</source><year>2004</year><volume>89</volume><fpage>742</fpage><lpage>743</lpage><pub-id pub-id-type="pmid">15194541</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barton</surname><given-names>JC</given-names></name><name><surname>Rao</surname><given-names>SV</given-names></name><name><surname>Pereira</surname><given-names>NM</given-names></name><name><surname>Gelbart</surname><given-names>T</given-names></name><name><surname>Beutler</surname><given-names>E</given-names></name><name><surname>Rivers</surname><given-names>CA</given-names></name><name><surname>Acton</surname><given-names>RT</given-names></name></person-group><article-title>Juvenile hemochromatosis in the southeastern United States: a report of seven cases in two kinships</article-title><source>Blood Cells Mol Dis</source><year>2002</year><volume>29</volume><fpage>104</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">12482411</pub-id><pub-id pub-id-type="doi">10.1006/bcmd.2002.0545</pub-id></citation></ref><ref id="B13"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Kaltwasser</surname><given-names>JP</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Barton JC and Edwards CQ</surname></name></person-group><article-title>Juvenile hemochromatosis</article-title><source>Hemochromatosis Genetics, pathophysiology, diagnosis, and treatment</source><year>2000</year><publisher-name>Cambridge, Cambridge University Press</publisher-name><fpage>318</fpage><lpage>328</lpage></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rivard</surname><given-names>SR</given-names></name><name><surname>Mura</surname><given-names>C</given-names></name><name><surname>Simard</surname><given-names>H</given-names></name><name><surname>Simard</surname><given-names>R</given-names></name><name><surname>Grimard</surname><given-names>D</given-names></name><name><surname>Le Gac</surname><given-names>G</given-names></name><name><surname>Raguenes</surname><given-names>O</given-names></name><name><surname>Ferec</surname><given-names>C</given-names></name><name><surname>De Braekeleer</surname><given-names>M</given-names></name></person-group><article-title>Clinical and molecular aspects of juvenile hemochromatosis in Saguenay-Lac-Saint-Jean (Quebec, canada)</article-title><source>Blood Cells Mol Dis</source><year>2000</year><volume>26</volume><fpage>10</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">10772871</pub-id><pub-id pub-id-type="doi">10.1006/bcmd.2000.0271</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>AL</given-names></name><name><surname>Rhodes</surname><given-names>DA</given-names></name><name><surname>Roland</surname><given-names>JM</given-names></name><name><surname>Schofield</surname><given-names>P</given-names></name><name><surname>Cox</surname><given-names>TM</given-names></name></person-group><article-title>Hereditary juvenile haemochromatosis: a genetically heterogeneous life-threatening iron-storage disease</article-title><source>QJM</source><year>1998</year><volume>91</volume><fpage>607</fpage><lpage>618</lpage><pub-id pub-id-type="pmid">10024915</pub-id><pub-id pub-id-type="doi">10.1093/qjmed/91.9.607</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Varkonyi</surname><given-names>J</given-names></name><name><surname>Kaltwasser</surname><given-names>JP</given-names></name><name><surname>Seidl</surname><given-names>C</given-names></name><name><surname>Kollai</surname><given-names>G</given-names></name><name><surname>Andrikovics</surname><given-names>H</given-names></name><name><surname>Tordai</surname><given-names>A</given-names></name></person-group><article-title>A case of non-HFE juvenile haemochromatosis presenting with adrenocortical insufficiency</article-title><source>Br J Haematol</source><year>2000</year><volume>109</volume><fpage>252</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">10896410</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2141.2000.01987.x</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Montes-Cano</surname><given-names>M</given-names></name><name><surname>Gonzalez-Escribano</surname><given-names>MF</given-names></name><name><surname>Aguilar</surname><given-names>J</given-names></name><name><surname>Nunez-Roldan</surname><given-names>A</given-names></name></person-group><article-title>Juvenile hemochromatosis in a Spanish family</article-title><source>Blood Cells Mol Dis</source><year>2002</year><volume>28</volume><fpage>297</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">12064925</pub-id><pub-id pub-id-type="doi">10.1006/bcmd.2002.0518</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roetto</surname><given-names>A</given-names></name><name><surname>Totaro</surname><given-names>A</given-names></name><name><surname>Cazzola</surname><given-names>M</given-names></name><name><surname>Cicilano</surname><given-names>M</given-names></name><name><surname>Bosio</surname><given-names>S</given-names></name><name><surname>D'Ascola</surname><given-names>G</given-names></name><name><surname>Carella</surname><given-names>M</given-names></name><name><surname>Zelante</surname><given-names>L</given-names></name><name><surname>Kelly</surname><given-names>AL</given-names></name><name><surname>Cox</surname><given-names>TM</given-names></name><name><surname>Gasparini</surname><given-names>P</given-names></name><name><surname>Camaschella</surname><given-names>C</given-names></name></person-group><article-title>Juvenile hemochromatosis locus maps to chromosome 1q</article-title><source>Am J Hum Genet</source><year>1999</year><volume>64</volume><fpage>1388</fpage><lpage>1393</lpage><pub-id pub-id-type="pmid">10205270</pub-id><pub-id pub-id-type="doi">10.1086/302379</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feder</surname><given-names>JN</given-names></name><name><surname>Gnirke</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>W</given-names></name><name><surname>Tsuchihashi</surname><given-names>Z</given-names></name><name><surname>Ruddy</surname><given-names>DA</given-names></name><name><surname>Basava</surname><given-names>A</given-names></name><name><surname>Dormishian</surname><given-names>F</given-names></name><name><surname>Domingo</surname><given-names>RJ</given-names></name><name><surname>Ellis</surname><given-names>MC</given-names></name><name><surname>Fullan</surname><given-names>A</given-names></name><name><surname>Hinton</surname><given-names>LM</given-names></name><name><surname>Jones</surname><given-names>NL</given-names></name><name><surname>Kimmel</surname><given-names>BE</given-names></name><name><surname>Kronmal</surname><given-names>GS</given-names></name><name><surname>Lauer</surname><given-names>P</given-names></name><name><surname>Lee</surname><given-names>VK</given-names></name><name><surname>Loeb</surname><given-names>DB</given-names></name><name><surname>Mapa</surname><given-names>FA</given-names></name><name><surname>McClelland</surname><given-names>E</given-names></name><name><surname>Meyer</surname><given-names>NC</given-names></name><name><surname>Mintier</surname><given-names>GA</given-names></name><name><surname>Moeller</surname><given-names>N</given-names></name><name><surname>Moore</surname><given-names>T</given-names></name><name><surname>Morikang</surname><given-names>E</given-names></name><name><surname>Wolff</surname><given-names>RK</given-names></name></person-group><article-title>A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis</article-title><source>Nat Genet</source><year>1996</year><volume>13</volume><fpage>399</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">8696333</pub-id><pub-id pub-id-type="doi">10.1038/ng0896-399</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beutler</surname><given-names>E</given-names></name><name><surname>Gelbart</surname><given-names>T</given-names></name><name><surname>West</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>P</given-names></name><name><surname>Adams</surname><given-names>M</given-names></name><name><surname>Blackstone</surname><given-names>R</given-names></name><name><surname>Pockros</surname><given-names>P</given-names></name><name><surname>Kosty</surname><given-names>M</given-names></name><name><surname>Venditti</surname><given-names>CP</given-names></name><name><surname>Phatak</surname><given-names>PD</given-names></name><name><surname>Seese</surname><given-names>NK</given-names></name><name><surname>Chorney</surname><given-names>KA</given-names></name><name><surname>Ten Elshof</surname><given-names>AE</given-names></name><name><surname>Gerhard</surname><given-names>GS</given-names></name><name><surname>Chorney</surname><given-names>M</given-names></name></person-group><article-title>Mutation analysis in hereditary hemochromatosis</article-title><source>Blood Cells Mol Dis</source><year>1996</year><volume>22</volume><fpage>187</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">8931958</pub-id><pub-id pub-id-type="doi">10.1006/bcmd.1996.0027</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beutler</surname><given-names>E</given-names></name></person-group><article-title>The significance of the 187G (H63D) mutation in hemochromatosis</article-title><source>Am J Hum Genet</source><year>1997</year><volume>61</volume><fpage>762</fpage><lpage>764</lpage><pub-id pub-id-type="pmid">9326341</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>PC</given-names></name><name><surname>Chakrabarti</surname><given-names>S</given-names></name></person-group><article-title>Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria</article-title><source>Gastroenterology</source><year>1998</year><volume>114</volume><fpage>319</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">9453492</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mura</surname><given-names>C</given-names></name><name><surname>Raguenes</surname><given-names>O</given-names></name><name><surname>Ferec</surname><given-names>C</given-names></name></person-group><article-title>HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis</article-title><source>Blood</source><year>1999</year><volume>93</volume><fpage>2502</fpage><lpage>2505</lpage><pub-id pub-id-type="pmid">10194428</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>E</given-names></name><name><surname>Henderson</surname><given-names>S</given-names></name><name><surname>Chin</surname><given-names>CY</given-names></name><name><surname>Olynyk</surname><given-names>J</given-names></name><name><surname>Beilby</surname><given-names>JP</given-names></name><name><surname>Reed</surname><given-names>WD</given-names></name><name><surname>Jeffrey</surname><given-names>GP</given-names></name></person-group><article-title>Genotyping as a diagnostic aid in genetic haemochromatosis</article-title><source>J Gastroenterol Hepatol</source><year>1999</year><volume>14</volume><fpage>427</fpage><lpage>430</lpage><pub-id pub-id-type="pmid">10355506</pub-id><pub-id pub-id-type="doi">10.1046/j.1440-1746.1999.01884.x</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gochee</surname><given-names>PA</given-names></name><name><surname>Powell</surname><given-names>LW</given-names></name><name><surname>Cullen</surname><given-names>DJ</given-names></name><name><surname>Du</surname><given-names>SD</given-names></name><name><surname>Rossi</surname><given-names>E</given-names></name><name><surname>Olynyk</surname><given-names>JK</given-names></name></person-group><article-title>A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation</article-title><source>Gastroenterology</source><year>2002</year><volume>122</volume><fpage>646</fpage><lpage>651</lpage><pub-id pub-id-type="pmid">11874997</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Camaschella</surname><given-names>C</given-names></name><name><surname>Roetto</surname><given-names>A</given-names></name><name><surname>Cali</surname><given-names>A</given-names></name><name><surname>De Gobbi</surname><given-names>M</given-names></name><name><surname>Garozzo</surname><given-names>G</given-names></name><name><surname>Carella</surname><given-names>M</given-names></name><name><surname>Majorano</surname><given-names>N</given-names></name><name><surname>Totaro</surname><given-names>A</given-names></name><name><surname>Gasparini</surname><given-names>P</given-names></name></person-group><article-title>The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22</article-title><source>Nat Genet</source><year>2000</year><volume>25</volume><fpage>14</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">10802645</pub-id><pub-id pub-id-type="doi">10.1038/75534</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beutler</surname><given-names>E</given-names></name><name><surname>Felitti</surname><given-names>V</given-names></name><name><surname>Gelbart</surname><given-names>T</given-names></name><name><surname>Ho</surname><given-names>N</given-names></name></person-group><article-title>The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic</article-title><source>Ann Intern Med</source><year>2000</year><volume>133</volume><fpage>329</fpage><lpage>337</lpage><pub-id pub-id-type="pmid">10979877</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beutler</surname><given-names>E</given-names></name><name><surname>Barton</surname><given-names>JC</given-names></name><name><surname>Felitti</surname><given-names>VJ</given-names></name><name><surname>Gelbart</surname><given-names>T</given-names></name><name><surname>West</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>PL</given-names></name><name><surname>Waalen</surname><given-names>J</given-names></name><name><surname>Vulpe</surname><given-names>C</given-names></name></person-group><article-title>Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans</article-title><source>Blood Cells Mol Dis</source><year>2003</year><volume>31</volume><fpage>305</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">14636643</pub-id><pub-id pub-id-type="doi">10.1016/S1079-9796(03)00165-7</pub-id></citation></ref></ref-list></back></article> 